Table 2. Predictors of mortality on univariate analysis.

HAGMA: high anion gap metabolic acidosis, eGFR: estimated glomerular filtration rate, PRISM3 score: Pediatric Risk of Mortality 3 score

Dependent: mortality		Yes	OR	P-value	95% CI
AKI type	Prerenal	17 (48.6)
	Renal	11 (39.3)	0.69	0.462	0.25–1.88
	Postrenal	0 (0.0)	0.00	0.991	0.00–Inf
Stage	Stage 1	3 (42.9)	-
	Stage 2	3 (60.0)	2.00	0.560	0.19–20.6
	Stage 3	22 (42.3)	0.98	0.978	0.20–4.82
Shock	Yes	17 (42.5)	0.87	0.795	0.32–2.42
Renal replacement therapy	Yes	18 (47.4)	1.44	0.481	0.52–3.97
Pneumonia	Yes	6 (75.0)	4.64	0.075	0.86–25.0
Acyanotic heart disease (VSD)	Yes	3 (37.5)	0.74	0.704	0.16–3.42
Age	3–12 months	8 (50.0)	-
	1–5 years	6 (40.0)	0.67	0.577	0.16–2.77
	6–10 years	5 (27.8)	0.38	0.188	0.09–1.60
	11–15 years	9 (60.0)	1.50	0.577	0.36–6.23
Gender	Male	16 (51.6)	-
	Female	12 (36.4)	0.54	0.221	0.20–1.46
Vomiting, loose stool	Yes	5 (23.8)	0.27	0.029	0.08–0.88
Decreased UO	Yes	2 (15.4)	0.17	0.033	0.04–0.87
Hyponatremia	Yes	9 (33.3)	1.20	0.344	0.28–2.94
HAGMA	Yes	26 (44.8)	1.34	0.148	0.08–4.8
eGFR	≥35 mL/1.73 m²	21 (55.3)	-
	<35 mL/1.73 m²	7 (26.9)	0.30	0.028	0.10–0.88
PRISM3 score	Mean (SD)	11.6 (3.5)	1.14	0.047	1.00–1.29
Ventilation requirements	Yes	22 (55.0)	3.67	0.022	1.20–11.1